• Publications
  • Influence
Surgical Management of Giant Condyloma Acuminatum (Buschke‐Loewenstein Tumor) of the Perianal Region
Giant condyloma acuminatum (GCA; BuschkeLoewenstein tumor) of the anogenital and perianal region is a rare, locally aggressive, disfiguring disease affecting the anogenital and perianal regions.Expand
  • 25
  • 1
The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression.
Breast cancer (BC) continues to affect the lives of millions of women worldwide. Several members of the carcinoembryonic antigen-related cell adhesion molecule (CEACAM) subfamily are involved inExpand
  • 24
  • 1
Juvenile Gigantomastia in a 12-Year-Old Girl: A Case Report
Juvenile gigantomastia is a rare, massive breast enlargement. It appears in adolescence and can affect one or both breasts of otherwise healthy girls. This report describes a case of a bilateral andExpand
  • 5
  • 1
A giant mesenteric lipoblastoma in an 18-month old infant: a case report and review of the literature.
Infantile lipoma (or lipoblastoma) of the mesentery is an extremely rare benign tumor of embryonal fat, with 15 cases reported in the English literature until today and only three of them arise fromExpand
  • 3
  • 1
Emerging indications for statins: a pluripotent family of agents with several potential applications.
Statins are pluripotent agents exhibiting multiple non-lipid-lowering actions. Besides their established role in the management of hypercholesterolemia, statins may also have beneficial actions inExpand
  • 73
BCL2L12: a promising molecular prognostic biomarker in breast cancer.
OBJECTIVES BCL2-like 12 (BCL2L12) is a new member of the BCL2 gene family that was discovered and cloned by members of our group and found to be expressed in the mammary gland. Many genes of the BCL2Expand
  • 15
Biweekly gemcitabine (GEM) in combination with erlotinib (ERL): an active and convenient regimen for advanced pancreatic cancer.
BACKGROUND Pancreatic cancer remains a disease of high mortality and one of the most frustrating, resistant solid neoplasms to treat. The aim of this study was to evaluate a biweekly gemcitabine plusExpand
  • 12
Statin use in patients with chronic kidney disease stages 2–4: targeting beyond improved mortality rates
The well-designed study by Neves et al. [1] showed that statin and/or vitamin D non-use were independent risk factors of mortality (p = 0.005) in their cohort of patients (n = 95) with chronic kidneyExpand
  • 5
Bevacizumab combined with two-weekly paclitaxel as first-line therapy for metastatic breast cancer.
BACKGROUND Metastatic breast cancer remains a major clinical issue despite progress achieved in recent years. Three randomised trials have demonstrated the benefit of combining bevacizumab withExpand
  • 5
Cardiovascular events in chronic dialysis patients: emphasizing the importance of vascular disease prevention
Cardiovascular disease is the leading cause of death in both chronic kidney disease and peritoneal dialysis/hemodialysis patients. Vascular disease prevention in these patients is therefore importantExpand
  • 20